"We are pleased to see that our latest incretin medicine meets our expectations for safety and tolerability, glucose control and weight loss, and we look forward to additional data readouts later this year" Over 65 percent of participants given the highest orforglipron dose attained an A1C level less than or equal to 6.5 percent
Oral administration of soy peptide (SP) has been reported to attenuate age-related cognitive decline in learning and memory in a mouse model of accelerated ageing (SAM), with increased expression of neurotrophic factors, such as BDNF and NT-3, observed in the brains of SP-fed mice at both the mRNA and protein levels (103)
Cheaper obesity medications could come to Canada this summer, as Health Canada reviews generics Having generics that might significantly reduce the price is welcome, obesity physician says Health Canada says it is reviewing nine submissions for generic versions of popular weight loss medications that pharmaceutical experts say could bring down the price
It is widely available as an over-the-counter dietary supplement, with the global market valued at $58.1 million in 2023, projected to grow to $97.5 million by 2033 [5]
In addition, MT-I and MT-II are available as research peptides for subcutaneous administration